Literature DB >> 10952645

Oxalate and calcium excretion in cystic fibrosis.

M A Turner1, D Goldwater, T J David.   

Abstract

BACKGROUND: A patient with cystic fibrosis (CF) and repeated calcium oxalate renal stones prompted us to investigate other children for risk factors for this recognised complication of CF.
METHODS: Twenty four hour urinary excretion of calcium, oxalate, and glycolate was measured in children with CF and no symptoms of renal tract stones. Normal diet and treatments were continued.
RESULTS: In 26 children (aged 5-15.9 years) oxalate excretion was correlated with age; 14 of 26 children had oxalate excretion above an age appropriate normal range. There was a positive correlation between oxalate excretion and glycolate excretion. Mean calcium excretion was 0.06 mmol/kg/24 h with 21 of 24 children having calcium excretion below the normal range.
CONCLUSIONS: Hyperoxaluria may reflect malabsorption although correlation between excretion of oxalate and glycolate suggests a portion of the excess oxalate is derived from metabolic processes. The hypocalciuria observed here may protect children with CF from renal stones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952645      PMCID: PMC1718467          DOI: 10.1136/adc.83.3.244

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Crohn's disease - a cause of arthritis, oxalate stones and fistulae in cystic fibrosis.

Authors:  A R Euler; M E Ament
Journal:  West J Med       Date:  1976-10

2.  Cross sectional stature and weight reference curves for the UK, 1990.

Authors:  J V Freeman; T J Cole; S Chinn; P R Jones; E M White; M A Preece
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

3.  A new enzymatic method for the determination of glycollate in urine and plasma.

Authors:  G P Kasidas; G A Rose
Journal:  Clin Chim Acta       Date:  1979-08-15       Impact factor: 3.786

Review 4.  The short-bowel syndrome.

Authors:  J M Nightingale
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-06       Impact factor: 2.566

5.  A common molecular basis for three inherited kidney stone diseases.

Authors:  S E Lloyd; S H Pearce; S E Fisher; K Steinmeyer; B Schwappach; S J Scheinman; B Harding; A Bolino; M Devoto; P Goodyer; S P Rigden; O Wrong; T J Jentsch; I W Craig; R V Thakker
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

6.  Ascorbic acid is an abettor in calcium urolithiasis: an experimental study.

Authors:  P P Singh; R Kiran; A K Pendse; R Gosh; S S Surana
Journal:  Scanning Microsc       Date:  1993-09

Review 7.  Dietary salt, urinary calcium, and kidney stone risk.

Authors:  L K Massey; S J Whiting
Journal:  Nutr Rev       Date:  1995-05       Impact factor: 7.110

Review 8.  Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development.

Authors:  S R Khan
Journal:  Urol Res       Date:  1995

9.  Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.

Authors:  H Sidhu; B Hoppe; A Hesse; K Tenbrock; S Brömme; E Rietschel; A B Peck
Journal:  Lancet       Date:  1998-09-26       Impact factor: 79.321

10.  Cystic fibrosis and calcium oxalate nephrolithiasis.

Authors:  A S Chidekel; T F Dolan
Journal:  Yale J Biol Med       Date:  1996 Jul-Aug
View more
  4 in total

Review 1.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

2.  Renal diseases in adults with cystic fibrosis: a 40 year single centre experience.

Authors:  M J Wilcock; A Ruddick; K M Gyi; M E Hodson
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

3.  Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.

Authors:  Ristan M Greer; Helen M Buntain; Julia M Potter; Claire E Wainwright; Joseph C Wong; Peter K O'Rourke; Paul W Francis; Scott C Bell; Jennifer A Batch
Journal:  Osteoporos Int       Date:  2003-04-08       Impact factor: 4.507

4.  Predisposing factors for nephrolithiasis and nephrocalcinosis in cystic fibrosis.

Authors:  Hamid-Reza Kianifar; Saeedeh Talebi; Mahmoodreza Khazaei; Saeed Talebi; Ali Alamdaran; Simin Hiradfar
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.